Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

NCT00246636 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Antara (fenofibrate) + Lovaza
DRUG: Antara (fenofibrate)

Sponsor

GlaxoSmithKline